Piotrode Medical AB

Piotrode Medical AB has developed new technology platforms for biopotential sensors. In 2018 the company Piotrode Medical AB was created and is now working with licensing and integration of the technology in market leading products. Piotrode has developed 2 technical platforms which can be deployed on biopotential sensors and biopotential recording devices. We are currently raising money for our technology deployment plan that entails establishing a new Golden Standard for ECG measurements by commercializing three ECG sensors in 2024 and in a second phase introduce a paradigm shift in ECG measurements . Piotrode Medical AB supplies technology for unique ECG electrodes and equipment. Prior Art sensor technology is the main limiting factor why remote patient monitoring hasn’t been able to deliver the potential benefits to health and wellbeing. The new technology platforms from from Piotrode Medical AB has this potential and could subsequently offer the possibility to reduce cost for the health care systems as expected by various stakeholders. Extensive experience in establishing new clinical methodology and commercialization of MedTech products on a global level.